Cargando…
Dynamic Assessment of Plasma von Willebrand Factor and ADAMTS13 Predicts Mortality in Hospitalized Patients with SARS-CoV-2 Infection
Background: Plasma levels of von Willebrand factor (VWF) are significantly elevated in patients with coronavirus disease 2019 (COVID-19). However, dynamic changes and prognostic value of this biomarker in hospitalized patients with COVID-19 have not been determined. Methods: A total of 124 patients...
Autores principales: | Zhang, Quan, Bignotti, Antonia, Yada, Noritaka, Ye, Zhan, Liu, Szumam, Han, Zhe, Zheng, X. Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672082/ https://www.ncbi.nlm.nih.gov/pubmed/38002786 http://dx.doi.org/10.3390/jcm12227174 |
Ejemplares similares
-
Effects of convalescent plasma infusion on the ADAMTS13-von Willebrand factor axis and endothelial integrity in patients with severe and critical COVID-19
por: Zhang, Quan, et al.
Publicado: (2022) -
Elevated Plasma Levels of Von Willebrand Factor and Syndecan-1 Predict 60-Day Mortality in Patients with Severe and Critical COVID-19
por: Zhang, Quan, et al.
Publicado: (2022) -
Von Willebrand factor, ADAMTS13 and mortality in dialysis patients
por: Ocak, Gurbey, et al.
Publicado: (2021) -
ADAMTS‐13 and bleeding phenotype in von Willebrand disease
por: Boender, Johan, et al.
Publicado: (2020) -
The von Willebrand factor – ADAMTS‐13 axis in malaria
por: O’Donnell, Andrew S., et al.
Publicado: (2022)